Signals, Powered By EquityPandit
Suven Life Sciences has got a patent from Australia for a drug that is used in treating disorders that are associated with neurodegenerative diseases.
It has said in a BSE filing that the company has been granted one product patent from Australia corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases.
Venkat Jasti, Suven Life CEO has said that “We are pleased by the grant of this patent to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally.”
